Preliminary evaluation on the effects of VG99 on some clinical and laboratory parameters in patients with chronic hepatitis B
- Author:
Vu -- Nam
- Publication Type:Journal Article
- Keywords:
chronic hepatitis B, treatment, signal
- MeSH:
Hepatitis B, Chronic;
Patients;
Medicine, Traditional
- From:Journal Reasearch of Vietnam Traditional Medicine and Pharmacy
2003;0(11):36-40
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
The fluid extract VGG was processed from Phyllanthus amarus, Adenosma caeruleum, Plantago asiatica, Centella asiatica, Schisandra chinensis, Curcuma aromatica and Rheum officinale. The acute toxicity experiment proved that VGG was nontoxic. The clinical trial included 18 chronic hepatitis B sufferers receiving VGG 50ml/day for 2 months. The study results showed a significant improvement in almost clinical symptoms, and a decline in transaminase level. There was no change in bilirubin, total protein. From the point of view of diseases classification in traditional medicine, VGG effect was better for patients with liver-heat and spleen-damp syndromes than those with stag nation of the liver-qi and deficiency of the spleen. No adverse drug reactions were observed
